Acetylon Pharmaceuticals, Inc. — Form D
Acetylon Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-08-10. The offering totals $8.0M, of which $7.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-08-10
- Form: D
- Accession: 0001469566-09-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $8.0M
- Amount sold: $7.3M
- Remaining: $750K
- Minimum investment: $100K
- Investors: 11
- Date of first sale: 2009-07-24
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-133465
Issuer
- Name: Acetylon Pharmaceuticals, Inc.
- CIK: 0001469566
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: Seaport Center, BOSTON, MA, 02210
- Phone: 617-245-1300
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Kenneth Anderson | Director | Wellesley, MA |
| James Bradner | Director | Boston, MA |
| Bruce L Downey | Director | Radnor, PA |
| WALTER C OGIER | Director | CAMBRIDGE, MA |
| Elena Prokupets | Director | North Andover, MA |
| WALTER C OGIER | Executive Officer | CAMBRIDGE, MA |
| Elena A Prokupets | Director | Cambridge, MA |
| Marc A Cohen | Director | Cambridge, MA |
| Marc A Cohen | Executive Officer | Cambridge, MA |
| Kenneth A Anderson | Director | Cambridge, MA |
| Walter A Ogier | Director | Irvine, CA |
| Walter A Ogier | Executive Officer | Irvine, CA |
| Bruce A Downey | Director | Boston, MA |
| James A Bradner | Director | Boston, MA |
Other filings by this issuer (2)
More